Role of arbutin in the inhibition of FBXO5 in hepatocellular carcinoma
FBXO5 is a potential diagnostic and prognostic biomarker for HCC, and arbutin may exert anticancer effects through the suppression of FBXO5 expression.
Authors
- Xueshan Pan (ORCID: https://orcid.org/0000-0002-9810-3475)
- Zheng Huang (ORCID: https://orcid.org/0000-0003-1818-7494)
- Kai Yao (ORCID: https://orcid.org/0000-0002-2570-2741)
- Yu Pi (ORCID: https://orcid.org/0000-0003-1320-0290)
- Tonggang Li
- Shuo Zhang (ORCID: https://orcid.org/0009-0000-4910-7456)
- Sen Yang (ORCID: https://orcid.org/0000-0002-8487-9619)
Institutions
- Bengbu Medical College (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1007/s12672-024-01729-z
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Anhui Provincial Department of Education